Practical management of adverse events in patients receiving tarlatamab, a delta‐like ligand 3–targeted bispecific T‐cell engager immunotherapy, for previously treated small cell lung cancer

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Jacob M. Sands, Stéphane Champiat, Horst‐Dieter Hummel, Kelly G. Paulson, Hossein Borghaei, Jean Bustamante Alvarez, David P. Carbone, Jennifer W. Carlisle, Noura J. Choudhury, Jeffrey M. Clarke, Shirish M. Gadgeel, Hiroki Izumi, Alejandro Navarro, Sally C. M. Lau, Philip E. Lammers, Shuang Huang, Ali Hamidi, Sujoy Mukherjee, Taofeek K. Owonikoko
Format:	Artículo Open Access
Published:	Wiley 2025
Subjects:	Cancer
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Internet